Автор: EurMa
AVIFAVIR
Introducing AvifavirAvifavir is the first Favipiravir-based drug in the world approved for the treatment of COVID-19. Favipiravir-based drugs have demonstrated efficacy in three independent clinical trials in Russia involving more than 700 patients with confirmed cases of COVID-19, as well as in ...
About Us
«European Medical Alliance» company was conceived as a response to the urgent needs of the pharmaceutical industry in quality and efficient consulting services in the field of market analysts. In 2020, we performed the first projects, including preinvestment audit projects and business diagnost...
Our partners
Our partnersPrivate and public charitable foundations, National research centers, government agencies, commercial organizations, leading distributors in different countries.
European Medical Alliance
Our group of companies and organizations has many years of experience and cooperation with colleagues from all over the world. We offer the newest and revolutionary drugs in various directions on the medical market. READ MORE
Main directions of work of EuRMA
We advise companies, owners and financial institutions in risk assessment, marketing analysis, commercial operations — those which are planning to attract financing, invest or divest. READ MORE
Marketing audit
Marketing auditAudit of market potential opportunities: current position in the market and possible prospects. Analysis of the company’s key markets: its competitors, demand potential, consumption structure and main stakeholders in the distribution chain.
Our clients
Our clientsPharmaceutical manufacturers: generic and patented products. Medical equipment manufacturers. Investment banks and Private equity funds. Healthcare companies.
Export and import audit
Export and import auditAnalysis of export-import opportunities, assessment of growth potential, prospects of entering new markets. Audit of the procurement of raw materials, production equipment.
Operational audit
Operational auditAudit and assessment of the management team, manufacturing process audit. Audit of a distribution system and analysis of suppliers and customers.